Rare diseases
Investigational molecules
Locations
Back to Italy885 clinical trials in Prato, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Long-Term Safety of Nintedanib for Children and Adolescents with Interstitial Lung Disease
ItalyStudy on KER-050 and Ruxolitinib for Patients with Myelofibrosis and Anemia
ItalyStudy Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
ItalyStudy Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression
ItalyStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
ItalyStudy of treatment discontinuation with nilotinib and asciminib in adults with chronic myeloid leukemia to achieve treatment-free remission
ItalyStudy of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation
ItalyStudy on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
ItalyStudy on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies
ItalyStudy Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments
ItalyStudy on the Safety and Effectiveness of Trifluridine/Tipiracil, Capecitabine, and Bevacizumab for Patients with Metastatic Colorectal Cancer Unfit for Intensive Chemotherapy
ItalyStudy of Chemotherapy with Osimertinib in Non-Small Cell Lung Cancer Patients Who Have Progressed After Initial Osimertinib Treatment
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, including innovative therapies and maintenance strategies.
Multiple studies evaluating novel drug combinations and personalized treatment approaches for various breast cancer subtypes.
Innovative research in colorectal cancer and pancreatic cancer, exploring new treatment combinations and maintenance therapies.
Studies focus on improving survival rates and treatment effectiveness for advanced gastrointestinal cancers.
Research targeting ovarian cancer and related conditions, with emphasis on platinum-sensitive diseases and novel therapeutic combinations.
Trials exploring new approaches for treating various types of gynecologic cancers with innovative drug combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
